Tags:Product
Focused on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases. (NASDAQ: ANTH)

Investors 1

Mentions in press and media 2

DateTitleDescriptionCategoryAuthorSource
14.08.2008Anthera Ph...Anthera Pharmaceuticals has ra...--venturebea...
13.09.2006San Francisco’s Anthera Phar...--venturebea...